SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Enovix Corp. engages in the design and development of silicon-anode lithium-ion batteries. The firm's proprietary 3D cell architecture increases energy density and maintains a high cycle life. It is also developing its 3D cell technology and production process for the electric vehicle and energy storage markets to help enable utilization of renewable energy. The company was founded by Mr. Harrold Jones Rust, III, Ashok Lahiri, and Murali Ramasubramanian in November 2006 and is headquartered in Fremont, CA.

Enovix Corporation

Enovix Corp

Enovix is currently seeing intense community debate as the stock navigates a volatile period near all-time lows, with investors weighing the potential for a technical bounce against concerns over production scaling and manufacturing yield hurdles. While some market participants remain focused on the long-term potential of the company's silicon-anode battery technology and upcoming product milestones, others are actively trading based on short-term sentiment, skepticism over management's execution, and high short interest.

Avis Budget Group, Inc. engages in the provision of vehicle sharing and rental services. It operates through the Americas and International segments. The Americas segment includes vehicle rental and car sharing operations in North America, South America, Central America, and the Caribbean. The International segment is involved in vehicle rental and car sharing operations in Europe, the Middle East, Africa, Asia, and Australasia. The company was founded in 1946 and is headquartered in Parsippany, NJ.

Avis Budget Group Inc

Avis Budget Group (CAR) is currently experiencing intense market volatility, driven by a blend of speculative short-squeeze activity and skepticism regarding its fundamental financial health, including high debt levels and negative free cash flow. While the stock has seen aggressive price swings and heavy institutional interest, the community remains sharply divided, with bulls pointing to potential recovery catalysts and bears warning that current price levels are disconnected from the company's long-term operational challenges.

The Wendy’s Co. engages in operating, developing, and franchising a system of quick-service restaurants. It operates through the following segments: Wendy’s U.S., Wendy’s International, and Global Real Estate and Development. The Wendy’s U.S. segment includes the operation and franchising of Wendy’s restaurants in the U.S. The Wendy’s International segment is involved in the operation and franchising of Wendy’s restaurants in countries and territories other than the U.S. The Global Real Estate and Development segment focuses on real estate activity for owned sites and sites leased from third parties. The company was founded by R. David Thomas on November 15, 1969 and is headquartered in Dublin, OH.

Wendy`s Co - Ordinary Shares - Class A

Wendy's Co

Wendy's is currently a focal point for investors due to heavy short interest, widespread speculation regarding a potential privatization or buyout deal, and an aggressive international expansion strategy. Community discussion remains polarized, with many retail traders actively accumulating shares and advocating for a short squeeze while others express frustration over the delayed CEO search and inconsistent store performance.

Luckin Coffee, Inc. engages in providing food and beverage items, and operates coffee retail stores. It has a pioneered a technology-driven retail network to provide coffee and other products of high quality, high convenience and high affordability to customers. The company manages pick-up stores, relax stores, and delivery kitchens. It also offers tea, snacks, and light meals through its mobile application. The company was founded by Zhi Ya Qian, Fei Yang and Jin Yi Guo on June 16, 2017 and is headquartered in Xiamen, China.

Luckin Coffee Inc - ADR

Luckin Coffee is generating intense debate as investors weigh the stock's significant growth and potential relisting catalysts against volatility and concerns regarding majority shareholder control. The community is actively discussing recent insider filings, the strategic implications of the Blue Bottle acquisition, and the potential for a rebound as China's coffee consumption expands.

Kratos Defense & Security Solutions, Inc. engages in the provision of mission critical products, services and solutions for United States national security priorities. It operates through the Kratos Government Solutions (KGS) and Unmanned Systems (US) segments. The KGS segment consists of an aggregation of KGS operating segments, including microwave electronic products, space, satellite and cyber, training solutions. The US segment refers to the unmanned aerial, unmanned ground, unmanned seaborne and related command, control and communications system businesses. The company was founded on December 19, 1994, and is headquartered in Round Rock, TX.

Kratos Defense & Security Solutions Inc

Kratos Defense is trending following a massive $1.2 billion secondary stock offering, an aggressive capital raise that investors are weighing against the company's strong hypersonic and drone contract pipeline. While the dilution has triggered short-term volatility, the community remains heavily focused on the stock's long-term growth potential tied to rising defense spending and its critical role in autonomous military systems.

Target Corp. engages in the operation and ownership of general merchandise stores. It offers food and general merchandise, clothing and household goods, electronics, and toys. Its brands include A New Day, All in Motion, Art Class, Auden, AVA & VIV, Boots and Barkley, Brightroom, Bullseye's Playground, Casaluna, Cat & Jack, Cloud Island, Colsie, dealworthy, Embark, Everspring, Favorite Day, Figmint, Future Collective, Gigglescape, Good & Gather, Goodfellow & Co, Hearth & Hand with Magnolia, Heyday, Hyde & EEK! Boutique, JoyLab, Kindfull, Kona Sol, Made By Design, Market Pantry, Mondo Llama, More Than Magic, Opalhouse, Open Story, Original Use, Pillowfort, Project 62, Room Essentials, Shade & Shore, Smartly, Smith & Hawken, Sonia Kashuk, Spritz, Sun Squad, Threshold, Universal Thread, up&up, Wild Fable, Wondershop, Xhilaration, California Roots, Casa Cantina, The Collection, Headliner, Jingle & Mingle, Rosé Bae, Photograph, SunPop, and Wine Cube. The company was founded by George Draper Dayton in 1902 and is headquartered in Minneapolis, MN.

Target Corp

Target is gaining momentum as investors react to a strategic leadership shakeup and a refocus on store staffing, while community sentiment remains divided between those betting on a value-driven turnaround and critics concerned about ongoing political headwinds and consumer spending shifts.

Viridian Therapeutics, Inc. is a biopharmaceutical company that develops medicines for autoimmune and rare diseases. It uses antibody discovery and protein engineering to create new therapies. The company is advancing late-stage IGF-1R therapies for thyroid eye disease (TED) and developing a potential TSHR-targeted treatment for TED and Graves’ disease. In addition, it is developing FcRn inhibitors, including VRDN-006 and VRDN-008, for multiple autoimmune diseases. The company was founded by William S. Marshall and Bruce L. Booth in February 2006 and is headquartered in Waltham, MA.

Viridian Therapeutics Inc

Viridian Therapeutics is facing significant downward pressure following its latest Phase 3 clinical trial results for elegrobart, which investors found underwhelming compared to competitors. While the company maintains that its subcutaneous delivery profile offers a potential advantage in the market, the community is actively debating the significance of the efficacy gap against established treatments and closely monitoring heavy put-side options activity.

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.

Replimune Group Inc

Replimune Group is trending due to the upcoming April 10 PDUFA date for RP1, with the community deeply divided between bullish investors betting on FDA approval following the recent BLA resubmission and bearish traders anticipating a second Complete Response Letter (CRL) based on historical efficacy concerns. Discussions are heavily focused on the high-stakes binary nature of this regulatory event, with many participants debating the potential for a share price collapse or a short squeeze given the significant short interest and volatile options flow.

Aehr Test Systems engages in the design, manufacture, market, and sale of test and burn-in equipment used in the semiconductor industry. Its products include FOX-XP, FOX-NP, and FOX-CP wafer contact parallel test and burn-in systems, the WaferPak full wafer contactor, the DiePak Carrier, the WaferPak Aligner, the DiePak Autoloader, and test fixtures. The company was founded by Rhea J. Posedel on May 25, 1977 and is headquartered in Fremont, CA.

Aehr Test Systems

Aehr Test Systems is seeing a surge in investor attention as the community anticipates major contract announcements linked to the company's role as a critical gatekeeper in AI chip reliability. Investors are actively discussing the potential for a rerating as the firm pivots toward hyperscale data center infrastructure, though some remain cautious due to historical earnings volatility and high expectations ahead of upcoming financial reports.

Digimarc Corp. provides digital watermarking technology services. It develops solutions, licenses intellectual property, and provides development services. The company also connects print, audio, and packaging to brand-defined online content, protects, identifies, and tracks digital files, and confirms content and objects are genuine, unaltered, and from an authorized source. Its products include Digimarc Validate, Digimarc Engage, Digimarc Recycle and Digimarc Retail Experience. The company was founded on January 3, 1995 and is headquartered in Beaverton, OR.

Digimarc Corporation

Digimarc is trending as investors focus on a pending CUSIP change and growing anticipation for the company's secure gift card solutions to curb market-wide fraud. Discussion is heavily focused on the stock's high short interest, potential for a short squeeze, and community-driven skepticism regarding leadership's ability to capitalize on recent technological wins.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Craig Hallum Initiates Coverage on CryoPort (NASDAQ:CYRX)

Craig Hallum began coverage on CryoPort in a research report on Monday. They issued a "buy" rating and a $15.00 price target on the stock...

Insider Selling: CryoPort (NASDAQ:CYRX) Insider Sells 1,341 Shares of Stock

CryoPort, Inc. (NASDAQ:CYRX - Get Free Report) insider Mark Sawicki sold 1,341 shares of the company's stock in a transaction on Monday, March 23rd. The shares were sold at an average price of $8.18...

CryoPort (NASDAQ:CYRX) Insider Sells $10,969.38 in Stock

CryoPort, Inc. (NASDAQ:CYRX - Get Free Report) insider Mark Sawicki sold 1,341 shares of CryoPort stock in a transaction dated Monday, March 23rd. The stock was sold at an average price of $8.18, for...

CryoPort (NASDAQ:CYRX) CEO Jerrell Shelton Sells 2,894 Shares of Stock

CryoPort, Inc. (NASDAQ:CYRX - Get Free Report) CEO Jerrell Shelton sold 2,894 shares of the stock in a transaction dated Monday, March 23rd. The shares were sold at an average price of $8.18, for a...

CryoPort, Inc. (NASDAQ:CYRX) Receives Average Recommendation of "Moderate Buy" from Brokerages

CryoPort, Inc. (NASDAQ:CYRX - Get Free Report) has received a consensus recommendation of "Moderate Buy" from the ten brokerages that are presently covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, one has issued a hol...

CryoPort (NASDAQ:CYRX) CEO Jerrell Shelton Sells 7,918 Shares

CryoPort, Inc. (NASDAQ:CYRX - Get Free Report) CEO Jerrell Shelton sold 7,918 shares of the firm's stock in a transaction that occurred on Monday, March 16th. The shares were sold at an average price...

CryoPort (NASDAQ:CYRX) Insider Edward Zecchini Sells 2,014 Shares

CryoPort, Inc. (NASDAQ:CYRX - Get Free Report) insider Edward Zecchini sold 2,014 shares of the stock in a transaction that occurred on Monday, March 16th. The stock was sold at an average price of...

CryoPort (NASDAQ:CYRX) Insider Mark Sawicki Sells 3,235 Shares

CryoPort, Inc. (NASDAQ:CYRX - Get Free Report) insider Mark Sawicki sold 3,235 shares of the firm's stock in a transaction dated Monday, March 16th. The stock was sold at an average price of $8.00...

Jerrell Shelton Sells 7,918 Shares of CryoPort (NASDAQ:CYRX) Stock

CryoPort, Inc. (NASDAQ:CYRX - Get Free Report) CEO Jerrell Shelton sold 7,918 shares of the business's stock in a transaction that occurred on Monday, March 16th. The stock was sold at an average...

Mak Capital One LLC Acquires New Position in CryoPort, Inc. $CYRX

Mak Capital One LLC acquired a new stake in shares of CryoPort, Inc. (NASDAQ:CYRX - Free Report) in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange...

CryoPort, Inc. engages in the provision of logistics solutions to the life science industry. It also provides logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cells for clients worldwide, including points-of-care, clinical research organizations central laboratories, biopharmaceuticals, contract manufacturing, health centers, and university researchers. It offers personalized medicine, immunotherapies, cellular therapies, CAR T-cell therapies, stem cell therapies, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, bio-pharmaceuticals, infectious substances, and other commodities that require continuous exposure to certain ranges of precision-controlled temperatures. The company was founded on May 25, 1990 and is headquartered in Brentwood, TN.

CYRX
CryoPort Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest CYRX News

CYRXCryoPort Inc